In the field of urology, benign prostatic hyperplasia (BPH) affects over 50% of men aged 60 and older, leading to urinary symptoms that disrupt daily life. The Rezum surgical tool handle assembly offers a minimally invasive solution that delivers water vapor therapy to shrink prostate tissue, providing rapid symptom relief while preserving sexual function and enabling same-day discharge. This technology addresses key limitations of traditional treatments, improving patient outcomes with proven durability.
What Is the Current State of BPH Treatment and Its Challenges?
Benign prostatic hyperplasia impacts approximately 210 million men worldwide, with prevalence rising to 90% in men over 85. In the US alone, over 12 million men seek treatment annually for lower urinary tract symptoms (LUTS) caused by BPH.
Annual healthcare costs exceed $4 billion, driven by medications, procedures, and complications like urinary retention.
Patients face frequent nighttime urination, weak streams, and incomplete emptying, reducing quality of life by up to 40% according to symptom scores.
Why Do Pain Points Persist Despite Available Options?
Complications from untreated BPH include acute urinary retention in 10% of cases yearly, often requiring emergency catheterization.
Medication adherence drops to 50% within a year due to side effects like dizziness and sexual dysfunction.
Progressive prostate growth at 2-3% per year worsens symptoms, pushing 20% of patients toward invasive surgery within five years.
What Limits Traditional BPH Solutions?
Traditional medications like alpha-blockers provide symptom relief in 70% of cases but fail to halt prostate growth, leading to retreatment in 40% of patients over time.
Transurethral resection of the prostate (TURP), the historical gold standard, involves general anesthesia and 1-2 hour procedures, with hospital stays averaging 1-2 days and risks of bleeding or incontinence in 10-15% of cases.
Laser therapies reduce these risks but require specialized equipment and longer recovery, with retreatment rates around 15% at five years.
How Does the Rezum Surgical Tool Handle Assembly Work?
The Rezum system, featuring the handle assembly, generates and delivers steam injections via a transurethral device connected to a generator.
Key components include the syringe cradle for vapor delivery, delivery device port for RF energy and thermocouples, roller pump for saline flushing, and touchscreen interface for real-time monitoring.
HHG GROUP facilitates access to Rezum handle assemblies through its platform, connecting clinics with reliable suppliers of new and used units since 2010.
This setup enables precise treatment of prostate zones adjacent to the urethra, causing tissue ablation through vapor condensation and vascular collapse.
Which Advantages Does Rezum Offer Over Traditional Methods?
| Feature | Traditional TURP | Rezum Handle Assembly |
|---|---|---|
| Procedure Time | 60-120 minutes | 5-10 minutes |
| Anesthesia Required | General or spinal | Local only |
| Hospital Stay | 1-2 days | Same-day discharge |
| Retreatment Rate (5 yrs) | 10-15% | 4.4% |
| Sexual Function Impact | 10-15% risk of dysfunction | Preserved |
| Cost per Procedure | $10,000+ | $3,000-$5,000 |
HHG GROUP streamlines procurement of Rezum components, ensuring clinics secure verified equipment efficiently.
Data shows Rezum reduces IPSS scores by 50% at one year, outperforming medications long-term.
How Is the Rezum Handle Assembly Used Step by Step?
-
Prepare the generator: Power on, load saline syringe into cradle, connect delivery device to port.
-
Cystoscopy guidance: Insert device via urethra to target prostate lobes under local anesthesia.
-
Deliver vapor: Inject 1.3cc steam per site (up to 10 sites) for 9 seconds each, monitored on touchscreen.
-
Flush and remove: Use roller pump for saline irrigation, then withdraw device and export procedure data via USB.
-
Post-procedure: Patients void spontaneously; monitor for 24 hours.
HHG GROUP supports technicians with maintenance services for sustained reliability.
Who Benefits Most from Rezum in Real Scenarios?
Scenario 1: Active Retiree with Nocturia
Problem: 65-year-old with 4+ nightly voids, IPSS score 25.
Traditional: Alpha-blockers reduced voids to 3 but caused fatigue.
After Rezum: Voids dropped to 0-1, IPSS to 8 within 4 weeks.
Key Benefit: Regained 7 hours uninterrupted sleep, boosting energy.
Scenario 2: Working Professional with Retention Risk
Problem: 55-year-old executive with weak stream, 30cc residual urine.
Traditional: TURP considered but declined due to recovery time.
After Rezum: Residual urine <50cc, Qmax improved 150%.
Key Benefit: Avoided catheterization; returned to work next day.
Scenario 3: Patient Prioritizing Sexual Health
Problem: 62-year-old with LUTS and erectile concerns.
Traditional: Medications worsened performance.
After Rezum: Symptoms resolved; IIEF score unchanged.
Key Benefit: Maintained intimacy without side effects.
Scenario 4: Large Prostate Case
Problem: 70-year-old, 80g prostate, recurrent UTIs.
Traditional: Laser enucleation planned but risky.
After Rezum: Prostate volume reduced 30%, no UTIs in 12 months.
Key Benefit: Outpatient fix prevented escalation.
Why Act Now on Rezum Amid Evolving Trends?
BPH cases projected to rise 25% by 2030 with aging populations.
Minimally invasive therapies like Rezum gain AUA endorsement, with global procedures surpassing 150,000.
HHG GROUP positions clinics ahead by linking to suppliers, fostering sustainable equipment access.
Delayed action increases complication risks by 15% annually.
Frequently Asked Questions
How long does Rezum treatment last?
Durability extends to 5+ years, with 95% avoiding retreatment.
Is Rezum suitable for all prostate sizes?
Optimal for 30-80g prostates; consult for larger cases.
What recovery time follows Rezum?
Most resume activities in 3-4 days; catheter optional for 1-3 days.
Does Rezum require special training?
Urologists train in 1-2 sessions; handle assembly simplifies use.
Can HHG GROUP source Rezum parts reliably?
Yes, their platform verifies new/used assemblies with transaction protection.